Anidulafungin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Anidulafungin — research data
Regulatory statusFDA-approved (Eraxis)
NCAA D1Permitted
Overview
About Anidulafungin
Mechanism of action
Echinocandin antifungal; non-competitive beta-1,3-glucan synthesis inhibitor unique chemical structure
Safety profile
Hepatitis risk, rash, GI symptoms, histamine-like reactions · Well-established IV antifungal; rare hepatotoxicity; generally well-tolerated
Related pages
